- Home
- TRVI vs CSAN Comparison
TRVI vs CSAN Comparison
Compare TRVI & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRVI | CSAN |
|---|---|---|
| Founded | 2011 | 1936 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TRVI | CSAN |
|---|---|---|
| Price | $18.46 | $2.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $21.55 | $4.75 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $321.51 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.93 | $2.51 |
| 52 Week High | $20.22 | $6.01 |
Technical Indicators
Market Signals| Indicator | TRVI | CSAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 28.06 |
| Support Level | $17.46 | N/A |
| Resistance Level | $19.89 | $3.24 |
| Average True Range (ATR) | 0.87 | 0.12 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 56.37 | 1.76 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.